Mostrando 2 resultados de: 2
Filtros aplicados
Subtipo de publicación
Article(2)
Lowering cholesterol, blood pressure, or both to prevent cardiovascular events: Results of 8.7 years of follow-up of Heart Outcomes Evaluation Prevention (HOPE)-3 study participants
ArticleAbstract: Aims: Rosuvastatin (10 mg per day) compared with placebo reduced major adverse cardiovascular (CV) ePalabras claves:Cardiovascular disease, Primary Prevention, statinsAutores:Avezum A.J., Bosch J.J., Dagenais G.R., Dans A.M., DIaz R., Held C., Jansky P., Joseph P.G., Jung H., Keltai K., Keltai M., Khunti K., Leiter L.A., Lewis B.S., Liu L., Lonn E.M., Pais P., Parkhomenko A.N., PATRICIO LOPEZ -JARAMILLO, Peters R.J.G., Piegas L.S., Reid C.M., Sliwa K., Toff W.D., Varigos J.D., Xavier D., Yusoff K., Yusuf S., Zhu J.Fuentes:googlescopusRisk factors, cardiovascular disease, and mortality in South America: a PURE substudy
ArticleAbstract: Aims: In a multinational South American cohort, we examined variations in CVD incidence and mortalitPalabras claves:Cardiovascular disease, Mortality , SOUTH AMERICAAutores:Avezum A.J., Camacho-López P.A., DIaz R., Islam S., Joseph P.G., Lanas F., López-López J.P., Oliveira G.B.F., Orlandini A., PATRICIO LOPEZ -JARAMILLO, Rangarajan S., Seron P., Yusuf S.Fuentes:googlescopus